Skip to content
Research Article Open access CC BY 3.0

Determination of Angiotensin-Converting Enzyme Inhibitor, Perindopril Erbumine, in Bulk and Tablet Dosage Form with HPLC

Chatragadda Nagalakshmi, Avula Prameela Rani, Sunkara Bhawani, Chandra Bala Sekaran

Chemical Science International Journal · pp. 161–176 · Published 20 Nov 2012

10.9734/ACSJ/2012/2045

Abstract

Aim: To develop and validate a simple HPLC method for the determination of perindopril erbumine (PDE) in bulk and tablets. Place and Duration of Study: Rainbow Pharma Lab, Hyderabad, India, between April and June 2012. Methodology: The separation of PDE was carried out on a Zorbax XDB C8 (250 mm × 4.6 mm I.D., 5 μm particle size) analytical column. The mobile phase was phosphate buffer (pH 4.5)-acetonitrile (60:40 v/v). The flow rate and wavelength were set to 1.3 mL/min and 242 nm, respectively. As per ICH guidelines, the proposed method was validated. The developed method was successfully applied for the estimation of PDE in tablets and results were compared statistically with the official method. Results: The developed method showed a linear response from 8 to 80 μg/mL, with a regression coefficient (R2) of 0.9996. The LOD and LOQ were 2.4 and 8μg/mL, respectively. The selectivity studies showed that the method was selective and free from interfering common excipients. The intra- and inter-day RSD were in the range of 0.043-0.234% and 0.180-0.654%, respectively. The results of recovery studies were good. The stability data of the PDE indicate that the drug was stable for 72 hours. Conclusion: The developed method was linear, sensitive, selective, precise, accurate and robust, being suitable for routine quality control analyses of PDE.

Perindopril erbumine HPLC method development isocratic elution method validation.

References (24)

  1. 1 The perindopril in elderly people with chronic heart failure (PEP-CHF) study [DOI]
  2. 2 Perindopril [DOI]
  3. 3 First LC–MS/MS electrospray ionization validated method for the quantification of perindopril and its metabolite perindoprilat in human plasma and its application to bioequivalence study [DOI]
  4. 4 Spectrophotometric and atomic absorption spectrometric determination of ramipril and perindopril through ternary complex formation with eosin and Cu(II) [DOI]
  5. 5 Utility of certain π-acceptors for the spectrophotometric determination of perindopril [DOI]
  6. 6 Development and Validation of a Stability-Indicating Assay Method for Simultaneous Determination of Perindopril and Indapamide in Combined Dosage Form by Reversed-Phase High-Performance Liquid Chromatography [DOI]
  7. 7 Amperometric biosensor based on D-aminoacid oxidase for the R-perindopril assay [DOI]
  8. 8 The use of microcalorimetry and HPLC for the determination of degradation kinetics and thermodynamic parameters of Perindopril Erbumine in aqueous solutions [DOI]
  9. 9 S-perindopril assay using a potentiometric, enantioselective membrane electrode [DOI]
  10. 10 Screening for the Detection of Angiotensin-Converting Enzyme Inhibitors, Their Metabolites, and AT II Receptor Antagonists [DOI]
  11. 11 Derivatization-GAS Chromatographic Determination of Perindopril [DOI]
  12. 12 Determination of S-perindopril using a flow injection system with an amperometric biosensor [DOI]
  13. 13 Optimized and Validated Initial-Rate Method for the Determination of Perindopril Erbumine in Tablets [DOI]
  14. 14 Validation of a dissolution method with RP-HPLC analysis for Perindopril erbumine and Indapamide combination tablet [DOI]
  15. 15 Validated Chromatographic Methods for Simultaneous Determination of Amlodipine Besylate and Perindopril Arginine in Binary Mixtures and in Pharmaceutical Dosage Form [DOI]
  16. 16 DEVELOPMENT AND VALIDATION OF NEW HPLC METHOD FOR THE ESTIMATION OF PERINDOPRIL IN TABLET DOSAGE FORMS
  17. 17 A new radioimmunoassay for the determination of the angiotensin-converting enzyme inhibitor Perindopril and its active metabolite in plasma and urine: Advantages of a lysine derivative as immunogen to improve the assay specificity [DOI]
  18. 18 Biosensor for the Enantioselecttve Analysis of S-Perindopril [DOI]
  19. 19 Rp-hplc method for the determination of losartan potassium and perindopril erbumine in combined tablet dosage form.
  20. 20 Analysis of the angiotensin-converting enzyme inhibitors perindopril, lisinopril, and quinapril by HPLC [DOI]
  21. 21 Effects of perindopril treatment on hemostatic function in patients with essential hypertension in relation to angiotensin converting enzyme (ACE) and plasminogen activator inhibitor-1 (PAI-1) gene polymorphisms [DOI]
  22. 22 Quantitative analysis of perindopril erbumine in pharmaceutical preparations by spectrophotometry via ternary complex formation with Zn(II) and eosin and charge transfer complexation with iodine [DOI]
  23. 23 High-performance liquid chromatographic assay for perindopril in tablets
  24. 24 Antihypertensive efficacy of the ACE-inhibitor perindopril in the elderly [DOI]

Cited by 6

Direct Spectrophotometric Determination of Perindopril Erbumine and Enalapril Maleate in Pure and Pharmaceutical Dosage Forms using Bromocresol Green

Amir Alhaj Sakur, Bayan Balid · Research Journal of Pharmacy and Technology · 2021

Analytical Techniques for the Estimation of Perindopril Erbumine: A Review

Khyati Pathak, Mona Kaushal, Himani Patel · Current Pharmaceutical Analysis · 2021

Method development and validation of HPLC tandem/mass spectrometry for quantification of perindopril arginine and amlodipine besylate combination in bulk and pharmaceutical formulations

KS Jaganathan, Kalaiyarasi Duraisamy, MarothuVamsi krishna · Research in Pharmaceutical Sciences · 2017

Stability-Indicating Analytical Method Development and Validation of Thiocolchicoside and Ibuprofen in Tablet Dosage Form by RP-HPLC Method

Ankush P. Jadhav, Prasanna A. Datar, Tejashree R. Kedar · Journal of Drug Delivery and Therapeutics · 2022

Showing 4 of 6 known citations — external sources report more than can currently be individually listed.

Related research

Article metrics

Real usage data collected on this platform.

16

Page views

0

PDF downloads

3

Outbound clicks

6

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.